Basics Cassava Sciences, Inc. IPO Date: July 14, 2000 Sector: Healthcare Industry: Pharma Market Cap: $192.27M Activated in VL: True Average Daily Range Avg Daily Range: $1.09 | 4.34% Avg Daily Range (30 D): $0.19 | 5.54% Avg Daily Range (90 D): $0.11 | 4.07% Institutional Daily Volume Avg Daily Volume: 2.57M Avg Daily Volume (30 D): 4.25M Avg Daily Volume (90 D): 1.92M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 215 Avg Trade Size (Sh.) (90 D): 206 Institutional Trades Total Inst.Trades: 2,717 Avg Inst. Trade: $1.51M Avg Inst. Trade (30 D): $.75M Avg Inst. Trade (90 D): $1.48M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.71M Avg Closing Trade (30 D): $1.19M Avg Closing Trade (90 D): $3.6M Avg Closing Volume: 74.39K     News Oct 22, 2025 @ 12:00 PM Cassava Sciences Appoints Dawn C. Bir to the Board... Source: Cassava Sciences, Inc. Mar 3, 2025 @ 6:00 PM LEQEMBI Market Sales Reflect Growing Confidence in... Source: Delveinsight Feb 8, 2025 @ 4:19 PM SAVA Deadline in 2 Days: Kessler Topaz Meltzer & C... Source: N/A Feb 6, 2025 @ 6:49 PM The Gross Law Firm Announces the Filing of a Secur... Source: The Gross Law Firm Feb 6, 2025 @ 3:03 AM CASSAVA SCIENCES SHAREHOLDER ALERT: CLAIMSFILER RE... Source: Claimsfiler Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.92 $-.48 $-.58 Diluted EPS $-.92 $-.48 $-.58 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -44.22M $ -23.4M $ -27.94M Operating Income / Loss $ -45.39M $ -24.59M $ -30.62M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ -18.31M PE Ratio     Splits Dec 21, 2023:   14:10 May 10, 2017:   1:7